{
  "ticker": "ROG",
  "year": 2021,
  "name": "ROG",
  "ir_url": "",
  "data": {
    "Income Statement": {
      "Total net sales": "25,021.0",
      "Net system sales": "19,243.0",
      "Net service and field option sales": "5,778.0",
      "Total cost of sales": "12,462.7",
      "Cost of system sales": "9,547.6",
      "Cost of service and field option sales": "2,915.1",
      "Gross profit": "12,558.3",
      "Research and development (R&D) costs": "3,727.2",
      "Selling, general and administrative (SG&A) costs": "1,088.2",
      "Income from operations": "7,742.9",
      "Interest and other, net": "-93.3",
      "Income before income taxes": "7,649.6",
      "Income tax expense": "(1,242.0)",
      "Income after income taxes": "6,407.6",
      "Profit from equity method investments": "230.7",
      "Net income": "6,638.3",
      "Cost of sales": "492.7",
      "Selling, general and administrative costs": "10.4",
      "Revenue from contracts with customers": "Not explicitly labeled",
      "Wages and salaries": "4,477.7",
      "Social security expenses": "433.1",
      "Pension and retirement expenses": "346.3",
      "Share-based payments": "112.5",
      "Personnel expenses": "5,369.6",
      "Board of Management": "4.7",
      "Former Board of Management": "1.0",
      "Other employees": "744.2",
      "Total STI bonus expenses": "673.6",
      "Pension plan based on multi-employer union plan": "244.6",
      "Pension plans based on defined contribution and other plans": "101.7",
      "Income tax (expense) / benefit current": "(1,062.5)",
      "Income tax (expense) / benefit deferred": "(179.5)",
      "Income tax (expense) / benefit Netherlands": "(1,263.5)",
      "Income tax (expense) / benefit Foreign": "(174.0)",
      "Total income tax (expense) / benefit current": "(1,236.5)",
      "Total income tax (expense) / benefit deferred": "(5.5)",
      "Total income tax (expense) / benefit": "(1,242.0)",
      "Income tax expense based on ASML’s domestic rate": "(1,933.6)",
      "Effects of tax rates in foreign jurisdictions": "18.1",
      "Adjustments in respect of tax incentives": "707.8",
      "Adjustments in respect of prior years’ current taxes": "0.5",
      "Adjustments in respect of prior years’ deferred taxes": "12.6",
      "Movements in the liability for unrecognized tax benefits": "11.5",
      "Global minimum tax (expense) / benefit": "N/A",
      "Change in valuation allowance": "-67.2",
      "Equity method investments": "62.4",
      "Other (credits) and non-tax deductible items": "18.3",
      "Basic net income per ordinary share": "15.63",
      "Diluted net income per ordinary share": "15.60",
      "Total purchases": "3,141.2",
      "Research and development costs": "Not explicitly separated"
    },
    "Balance Sheet": {
      "Total shareholder equity": "15,580.9",
      "Balance sheet total": "38,197.3",
      "Cash and cash equivalents": "7,004.7",
      "Short-term investments": "1.5",
      "Accounts receivable, net": "4,061.2",
      "Finance receivables, net": "358.7",
      "Current tax assets": "209.5",
      "Contract assets": "168.7",
      "Inventories, net": "8,183.1",
      "Other assets": "664.1",
      "Total current assets": "20,651.5",
      "Deferred tax assets": "1,454.7",
      "Loans receivable": "1,093.1",
      "Equity method investments": "738.2",
      "Goodwill": "4,630.3",
      "Other intangible assets, net": "633.6",
      "Property, plant and equipment, net": "5,041.1",
      "Right-of-use assets": "401.1",
      "Total non-current assets": "15,992.1",
      "Total assets": "38,197.3",
      "Accounts payable": "2,646.0",
      "Accrued and other liabilities": "2,317.2",
      "Current tax liabilities": "253.3",
      "Current portion of long-term debt": "1,017.8",
      "Contract liabilities": "4,214.6",
      "Total current liabilities": "15,678.3",
      "Long-term debt": "3,990.3",
      "Deferred and other income tax liabilities": "287.8",
      "Total non-current liabilities": "7,177.7",
      "Total liabilities": "22,856.0",
      "Issued and outstanding shares": "37.3",
      "Share premium": "3,832.4",
      "Treasury shares at cost": "(506.5)",
      "Retained earnings": "12,094.3",
      "Accumulated other comprehensive income": "160.7",
      "Total shareholders’ equity": "15,580.9",
      "Total liabilities and shareholders’ equity": "38,197.3",
      "Lease liabilities": "336.7",
      "Less: non-current portion of accrued and other liabilities": "379.4",
      "Current portion of accrued and other liabilities": "1,937.8",
      "Less: current portion of long-term debt": "1,017.8",
      "Non-current portion of long-term debt": "3,576.4",
      "Liability for unrecognized tax benefits": "-237.7",
      "Deferred tax liabilities": "-30.5",
      "Deferred and other tax assets (liabilities)": "1,167.5",
      "Total liability for unrecognized tax benefits": "-237.7",
      "Balance of accrued interest and penalties": "-39.7",
      "Total liabilities for unrecognized tax benefits including interest and penalties": "-277.4",
      "Confirmed obligations outstanding at the end of the year": "0.3",
      "Derivative financial instruments": "53.8",
      "Money market funds": "5,482.3",
      "Loan receivable": "1,073.0",
      "Property, plant and equipment": "3,505.7"
    },
    "Cash Flow Statement": {
      "Net cash provided by (used in) operating activities": "8,970.1",
      "Net cash provided by (used in) investing activities": "(2,566.0)",
      "Net cash provided by (used in) financing activities": "(1,990.1)",
      "Effect of changes in exchange rates on cash": "17.3",
      "Net increase (decrease) in cash and cash equivalents": "4,431.3",
      "Cash and cash equivalents, end of period": "7,004.7",
      "Short-term investments, end of period": "1.5",
      "Cash and cash equivalents and short-term investments": "7,006.2",
      "Purchases of property, plant and equipment and intangible assets": "(1,789.0)",
      "Free cash flow": "7,181.1",
      "Net income": "6,638.3",
      "Depreciation and amortization": "818.5",
      "Impairment and loss on disposal": "20.9",
      "Share-based compensation expense": "112.5",
      "Inventory reserves": "492.7",
      "Deferred tax expense (benefit)": "71.6",
      "Equity method investments": "3.4",
      "Accounts receivable, net": "-733.1",
      "Finance receivables, net": "-65.5",
      "Inventories": "-1,507.6",
      "Other assets": "-1,055.5",
      "Accrued and other liabilities": "308.0",
      "Accounts payable": "804.5",
      "Current tax assets and liabilities": "635.1",
      "Contract assets and liabilities": "1,717.3",
      "Net cash provided by operating activities": "8,970.1",
      "Purchase of property, plant and equipment": "-1,785.4",
      "Purchase of intangible assets": "-3.6",
      "Purchase of short-term investments": "-321.0",
      "Maturity of short-term investments": "431.6",
      "Loans issued and other investments": "-582.4",
      "Net cash used in investing activities": "-2,566.0"
    }
  },
  "tokens_used": 163180
}